These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
390 related items for PubMed ID: 26656646
1. Oligodendrocyte death results in immune-mediated CNS demyelination. Traka M, Podojil JR, McCarthy DP, Miller SD, Popko B. Nat Neurosci; 2016 Jan; 19(1):65-74. PubMed ID: 26656646 [Abstract] [Full Text] [Related]
2. Neurological disorders: A second wave. Bray N. Nat Rev Neurosci; 2016 Feb; 17(2):76. PubMed ID: 26806625 [No Abstract] [Full Text] [Related]
3. The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy? Lee DH, Linker RA. Expert Opin Ther Targets; 2012 May; 16(5):451-62. PubMed ID: 22494461 [Abstract] [Full Text] [Related]
4. Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination. von Büdingen HC, Hauser SL, Fuhrmann A, Nabavi CB, Lee JI, Genain CP. Proc Natl Acad Sci U S A; 2002 Jun 11; 99(12):8207-12. PubMed ID: 12060766 [Abstract] [Full Text] [Related]
5. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Linington C, Berger T, Perry L, Weerth S, Hinze-Selch D, Zhang Y, Lu HC, Lassmann H, Wekerle H. Eur J Immunol; 1993 Jun 11; 23(6):1364-72. PubMed ID: 7684687 [Abstract] [Full Text] [Related]
6. Antigen-oriented T cell migration contributes to myelin peptide induced-EAE and immune tolerance. Zheng P, Fu H, Wei G, Wei Z, Zhang J, Ma X, Rui D, Meng X, Ming L. Clin Immunol; 2016 Aug 11; 169():36-46. PubMed ID: 27327113 [Abstract] [Full Text] [Related]
7. The DTA Mouse Model for Oligodendrocyte Ablation and CNS Demyelination. Traka M. Methods Mol Biol; 2019 Aug 11; 1936():295-310. PubMed ID: 30820906 [Abstract] [Full Text] [Related]
8. Role of Fas--FasL interactions in the pathogenesis and regulation of autoimmune demyelinating disease. Sabelko-Downes KA, Russell JH, Cross AH. J Neuroimmunol; 1999 Dec 11; 100(1-2):42-52. PubMed ID: 10695714 [Abstract] [Full Text] [Related]
9. Induction of progressive demyelinating autoimmune encephalomyelitis in common marmoset monkeys using MOG34-56 peptide in incomplete freund adjuvant. Jagessar SA, Kap YS, Heijmans N, van Driel N, van Straalen L, Bajramovic JJ, Brok HP, Blezer EL, Bauer J, Laman JD, 't Hart BA. J Neuropathol Exp Neurol; 2010 Apr 11; 69(4):372-85. PubMed ID: 20448482 [Abstract] [Full Text] [Related]
10. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. Marta CB, Oliver AR, Sweet RA, Pfeiffer SE, Ruddle NH. Proc Natl Acad Sci U S A; 2005 Sep 27; 102(39):13992-7. PubMed ID: 16172404 [Abstract] [Full Text] [Related]
11. Caspase-mediated oligodendrocyte cell death in the pathogenesis of autoimmune demyelination. Hisahara S, Okano H, Miura M. Neurosci Res; 2003 Aug 27; 46(4):387-97. PubMed ID: 12871760 [Abstract] [Full Text] [Related]
12. B cell recognition of myelin oligodendrocyte glycoprotein autoantigen depends on immunization with protein rather than short peptide, while B cell invasion of the CNS in autoimmunity does not. Dang AK, Jain RW, Craig HC, Kerfoot SM. J Neuroimmunol; 2015 Jan 15; 278():73-84. PubMed ID: 25595255 [Abstract] [Full Text] [Related]
13. Anti-MOG antibodies associated demyelination following encephalomeningitis: Case report. Zhang H, Yang Y, Luo X. J Neuroimmunol; 2021 Apr 15; 353():577519. PubMed ID: 33631487 [Abstract] [Full Text] [Related]
14. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets. Jagessar SA, Smith PA, Blezer E, Delarasse C, Pham-Dinh D, Laman JD, Bauer J, Amor S, 't Hart B. J Neuropathol Exp Neurol; 2008 Apr 15; 67(4):326-40. PubMed ID: 18379435 [Abstract] [Full Text] [Related]
15. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. Schluesener HJ, Sobel RA, Linington C, Weiner HL. J Immunol; 1987 Dec 15; 139(12):4016-21. PubMed ID: 3500978 [Abstract] [Full Text] [Related]
16. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes. Kerlero de Rosbo N, Mendel I, Ben-Nun A. Eur J Immunol; 1995 Apr 15; 25(4):985-93. PubMed ID: 7737302 [Abstract] [Full Text] [Related]
17. The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis. Kaushansky N, Eisenstein M, Zilkha-Falb R, Ben-Nun A. Autoimmun Rev; 2010 Feb 15; 9(4):233-6. PubMed ID: 19683076 [Abstract] [Full Text] [Related]
18. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, Johner C, Wekerle H, Krishnamoorthy G. Nature; 2011 Oct 26; 479(7374):538-41. PubMed ID: 22031325 [Abstract] [Full Text] [Related]
19. Follow-up study on Chinese children with relapsing MOG-IgG-associated central nervous system demyelination. Zhou J, Lu X, Zhang Y, Ji T, Jin Y, Xu M, Bao X, Zhang Y, Xiong H, Chang X, Jiang Y, Wu Y. Mult Scler Relat Disord; 2019 Feb 26; 28():4-10. PubMed ID: 30529926 [Abstract] [Full Text] [Related]
20. Preparation of highly purified human myelin oligodendrocyte glycoprotein in quantities sufficient for encephalitogenicity and immunogenicity studies. Abo S, Bernard CC, Webb M, Johns TG, Alafaci A, Ward LD, Simpson RJ, Kerlero de Rosbo N. Biochem Mol Biol Int; 1993 Aug 26; 30(5):945-58. PubMed ID: 8220243 [Abstract] [Full Text] [Related] Page: [Next] [New Search]